These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25332447)
21. Reply: Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols? Zange L; Noack C; Hahn K; Lipp A; Stenzel W Brain; 2016 Jan; 139(Pt 1):e6. PubMed ID: 26351269 [No Abstract] [Full Text] [Related]
22. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Woulfe JM; Gray MT; Munoz G Neurology; 2015 Sep; 85(9):834. PubMed ID: 26554094 [No Abstract] [Full Text] [Related]
23. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Ruffmann C; Parkkinen L Neurology; 2015 Sep; 85(9):834. PubMed ID: 26324865 [No Abstract] [Full Text] [Related]
24. Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies. Vivacqua G; Casini A; Vaccaro R; Fornai F; Yu S; D'Este L J Chem Neuroanat; 2011 Mar; 41(2):97-110. PubMed ID: 21172422 [TBL] [Abstract][Full Text] [Related]
25. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Totterdell S; Meredith GE Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475 [TBL] [Abstract][Full Text] [Related]
27. Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease? Cheshire WP; Pfeiffer RF Neurology; 2013 Oct; 81(18):1568-9. PubMed ID: 24089391 [TBL] [Abstract][Full Text] [Related]
30. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature. Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920 [TBL] [Abstract][Full Text] [Related]
31. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177 [TBL] [Abstract][Full Text] [Related]
32. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Jellinger KA Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530 [TBL] [Abstract][Full Text] [Related]
33. Reply to: Gray et al. Visanji NP; Marras C; Liu LW; Hazrati LN; Lang AE Mov Disord; 2014 Aug; 29(9):1225-6. PubMed ID: 24925804 [No Abstract] [Full Text] [Related]
34. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057 [TBL] [Abstract][Full Text] [Related]
35. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease. Lee JM; Derkinderen P; Kordower JH; Freeman R; Munoz DG; Kremer T; Zago W; Hutten SJ; Adler CH; Serrano GE; Beach TG J Neuropathol Exp Neurol; 2017 Jan; 76(1):2-15. PubMed ID: 28069931 [TBL] [Abstract][Full Text] [Related]